ALB and focal segmental glomerulosclerosis: To further clarify the therapeutic effect of the YSHS granule, we performed biochemical assays on mouse serum specimens, and the results showed that the YSHS granule elevated serum albumin (Figure 1C) and reduced serum creatinine (Figure 1D), triglyceride (Figure 1E), and total cholesterol (Figure 1F), which met the criteria for an effective treatment of FSGS.